Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter. MoonLake’s shares rose 19% in extended trading. Merck submitted a nonbinding offer for MoonLake earlier this year, according to the report, which added that the initial …
Merck held talks to buy biotech MoonLake for over $3 billion, FT reports Read More »










